Improving mRNA therapy for cancer treatment
Official title: Sequence optimization for mRNA cancer therapy
Funded at University of Washington · NIH-11063557 · Data updated 2026-11-12
This study is working on improving cancer treatments by using mRNA technology to create therapies that are more effective and have fewer side effects, so patients can receive more personalized care tailored to their specific cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | March 1, 2025 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $380,337 |
| NIH project number | 1R33CA286947-01A1 |
| Project ID | NIH-11063557 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with various types of cancer who may benefit from advanced mRNA therapies.
✕Less likely to help
Patients with non-cancerous conditions or those who do not respond to immunotherapy may not receive benefits from this research.
What this research studies
This research focuses on enhancing mRNA technology to develop more effective cancer therapies, particularly through immunotherapy. It aims to create a systematic model that can optimize the sequences of mRNA to improve protein expression and therapeutic outcomes. By utilizing advanced algorithms and computational methods, the project seeks to identify the best mRNA sequences for targeting specific cancer cells, potentially leading to more personalized and effective treatments. Patients may benefit from therapies that are designed to be more effective and have fewer side effects.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted cancer therapies that improve patient outcomes.
How similar studies have gone: Previous research has shown promising results in optimizing mRNA therapies for other conditions, indicating potential success for this approach in cancer treatment.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Seelig, Georg — University of Washington
- Study coordinator: Seelig, Georg
Related research
Other NIH-funded projects on the same topics.
-
Making genetic testing more accessible to the public
This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.
-
Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana
A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.
-
Binaural Hearing and Speech in Noise in Children
This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.
-
Neural circuits that control pain aversion in the brain
Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.
-
United World Antiviral Research Network (UWARN)
A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.
-
HF endotypes in heart failure using ethical multi-modal AI and molecular data
A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.